Back to Global NewsPublished: 18 Feb 2026Download AppJoin TelegramWhy J&J's $1B Cell Therapy Plant Could Flip the Pharma Landscape#Johnson & Johnson#cell therapy#pharma manufacturing#U.S. biotech#investmentDownload AppJoin CommunityShare Article